SGLT2 inhibition and three urological cancers: Up‐to‐date results

Abstract

We did not find any evidence that SGLT2 inhibition could increase the risk of the three cancers. Even in some analysis, SGLT2 inhibition tended to show protective effects on the three urological cancers.